FDA.reportPublic FDA data

Inqovi 35 MG / 100 MG Oral Tablet

RxCUI
2384464
RxNorm name
Inqovi 35 MG / 100 MG Oral Tablet
Display name
Inqovi 35 MG / 100 MG Oral Tablet
Full name
Inqovi 35 MG / 100 MG Oral Tablet
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
INQOVICEDAZURIDINE AND DECITABINETaiho Pharmaceutical Co., Ltd.91a0f80b-f865-4d06-a40d-4d148d99ee712026-05-25Warnings, Adverse reactionsExact identifier
rxcui: 2384464

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
91a0f80b-f865-4d06-a40d-4d148d99ee71INQOVI 35 MG / 100 MG Oral Tablet [PSN] · cedazuridine 100 MG / decitabine 35 MG Oral Tablet [Inqovi] [SBD] · Inqovi 35 MG / 100 MG Oral Tablet [SY]313These highlights do not include all the information needed to use INQOVI safely and effectively. See full prescribing information for INQOVI. INQOVI ® (decitabine and cedazuridine) tablets, for oral use Initial U.S. Approval: 202020260525